Related references
Note: Only part of the references are listed.ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia
Simona Sucha et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Drug rechanneling: A novel paradigm for cancer treatment
Itishree Kaushik et al.
SEMINARS IN CANCER BIOLOGY (2021)
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia
Jonathan Canaani et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance
Shuai Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs
Chung-Pu Wu et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer
Xiaoqun Shi et al.
CARBOHYDRATE POLYMERS (2021)
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Etoposide, an anticancer drug involved in therapy-related secondary leukemia: Enzymes at play
Wenchao Zhang et al.
TRANSLATIONAL ONCOLOGY (2021)
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers
Raffaele Di Francia et al.
CANCERS (2021)
An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells
Ewa Zeslawska et al.
BIOORGANIC CHEMISTRY (2021)
Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies-Current Research and Clinical Approaches
Anastazja Poczta et al.
JOURNAL OF CLINICAL MEDICINE (2021)
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
ATF3 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an N6-Methyladenosine-Based Epitranscriptomic Mechanism
Xiaochuan Liu et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2021)
Isobavachalcone as an Active Membrane Perturbing Agent and Inhibitor of ABCB1 Multidrug Transporter
Anna Palko-Labuz et al.
MOLECULES (2021)
Imidazole as a Promising Medicinal Scaffold: Current Status and Future Direction
Sahar S. Alghamdi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Actinomycin D Arrests Cell Cycle of Hepatocellular Carcinoma Cell Lines and Induces p53-Dependent Cell Death: A Study of the Molecular Mechanism Involved in the Protective Effect of IRS-4
Luis G. Guijarro et al.
PHARMACEUTICALS (2021)
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Sona Vodenkova et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Aptamer-Functionalized DNA Origami for Targeted Codelivery of Antisense Oligonucleotides and Doxorubicin to Enhance Therapy in Drug-Resistant Cancer Cells
Qingshan Pan et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma
Robert Chen et al.
CLINICAL CANCER RESEARCH (2020)
Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-Glycoprotein
Yu-Ning Teng et al.
MOLECULES (2020)
Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study
Sen-Ling Feng et al.
JOURNAL OF GINSENG RESEARCH (2020)
ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1
Norman Fultang et al.
SCIENTIFIC REPORTS (2020)
Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma
Wesam Ali et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
New insights into the cellular activities of Fndc5/Irisin and its signaling pathways
Farzaneh Rabiee et al.
CELL AND BIOSCIENCE (2020)
Molecular mechanism of action and pharmacokinetic properties of methotrexate
V Maksimovic et al.
MOLECULAR BIOLOGY REPORTS (2020)
Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance
Aneta Kaczor et al.
MOLECULES (2020)
Low-Dose Crizotinib, a Tyrosine Kinase Inhibitor, Highly and Specifically Sensitizes P-Glycoprotein-Overexpressing Chemoresistant Cancer Cells Through Induction of Late Apoptosis in vivo and in vitro
Kyeong Seok Kim et al.
FRONTIERS IN ONCOLOGY (2020)
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
Sandra Ferreira et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
FNDC5 promotes paclitaxel sensitivity of non-small cell lung cancers via inhibiting MDR1
Guo-Hua Fan et al.
CELLULAR SIGNALLING (2020)
Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells
Weiguo Feng et al.
FRONTIERS IN ONCOLOGY (2020)
Modulating the function of ABCB1:in vitroandin vivocharacterization of sitravatinib, a tyrosine kinase inhibitor
Yuqi Yang et al.
CANCER COMMUNICATIONS (2020)
A Sequentially Responsive Nanosystem Breaches Cascaded Bio-barriers and Suppresses P-Glycoprotein Function for Reversing Cancer Drug Resistance
Jia Liu et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Wilforine resensitizes multidrug resistant cancer cells via competitive inhibition of P-glycoprotein
Ying-Tzu Chang et al.
PHYTOMEDICINE (2020)
Repurposing old drugs to fight multidrug resistant cancers
Jelena Dinic et al.
DRUG RESISTANCE UPDATES (2020)
A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo
Rui-Ming Liu et al.
PHYTOMEDICINE (2020)
Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics
Jiun- Lai et al.
FRONTIERS IN ONCOLOGY (2020)
Antimicrobial, Anticancer and Multidrug-Resistant Reversing Activity of Novel Oxygen-, Sulfur- and Selenoflavones and Bioisosteric Analogues
Malgorzata Anna Marc et al.
PHARMACEUTICALS (2020)
N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H3 receptor and cancer resistance proteins
Katarzyna Szczepanska et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Comprehensive review on current developments of quinoline-based anticancer agents
Shweta Jain et al.
ARABIAN JOURNAL OF CHEMISTRY (2019)
Delivery of MTH1 inhibitor (TH287) and MDR1 siRNA via hyaluronic acid-based mesoporous silica nanoparticles for oral cancers treatment
Xiao-Lei Shi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells
Ying-Tzu Chang et al.
PHYTOMEDICINE (2019)
PgpRules: a decision tree based prediction server for P-glycoprotein substrates and inhibitors
Pei-Hua Wang et al.
BIOINFORMATICS (2019)
Self-assembled micelles based on N-octyl-N′-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel
Guowei Qu et al.
CARBOHYDRATE POLYMERS (2019)
Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5
Yoon Hyeon Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
Yu Toyoda et al.
FRONTIERS IN PHARMACOLOGY (2019)
Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals
Hamdan S. Al-malky et al.
CANCER CELL INTERNATIONAL (2019)
Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells
Rene Christena Lowrence et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2019)
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells
Zhuo-Xun Wu et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Teratogenic jervine increases the activity of doxorubicin in MCF-7/ADR cells by inhibiting ABCB1
Ming Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants
Christopher A. Eide et al.
CANCER CELL (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Synthesis of Mitomycin C and decarbamoylmitomycin C N6 deoxyadenosine-adducts
Maggie Zheng et al.
BIOORGANIC CHEMISTRY (2019)
Irinotecan: 25 years of cancer treatment
Christian Bailly
PHARMACOLOGICAL RESEARCH (2019)
Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps
Silvia Di Giacomo et al.
ARCHIVES OF TOXICOLOGY (2019)
Pharmacophoric features for a very potent 5-spirofluorenehydantoin inhibitor of cancer efflux pump ABCB1, based on X-ray analysis
Ewa Zeslawska et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer
S. G. Creemers et al.
ENDOCRINE-RELATED CANCER (2019)
Aminonaphthalimide hybrids of mitoxantrone and amonafide as anticancer and fluorescent cellular imaging agents
Alex D. Johnson et al.
BIOORGANIC CHEMISTRY (2019)
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1
Mariagrazia Rullo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Organoselenium Compounds as Novel Adjuvants of Chemotherapy DrugsA Promising Approach to Fight Cancer Drug Resistance
Gabriella Spengler et al.
MOLECULES (2019)
Redox-Responsive Core-Cross-Linked Block Copolymer Micelles for Overcoming Multidrug Resistance in Cancer Cells
Chiranjit Maiti et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
In Vitro Evaluation of the Multidrug Resistance Reversing Activity of Novel Imidazo[4,5-b]pyridine Derivatives
Selma Bourichi et al.
ANTICANCER RESEARCH (2018)
Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor
Wang Kai et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
Emanuela Martino et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCBI and ABCG2 transporters
Ying-Fang Fan et al.
CANCER LETTERS (2018)
Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives
Shagufta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Kinase-targeted cancer therapies: progress, challenges and future directions
Khushwant S. Bhullar et al.
MOLECULAR CANCER (2018)
Kinase inhibitors: the road ahead
Fleur M. Ferguson et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Epimagnolin A, a tetrahydrofurofuranoid lignan from Magnolia fargesii, reverses ABCB1-mediated drug resistance
Yuji Mitani et al.
PHYTOMEDICINE (2018)
The synergistic role of ATP-dependent drug efflux pump and focal adhesion signaling pathways in vinorelbine resistance in lung cancer
Takao Nakanishi et al.
CANCER MEDICINE (2018)
Targeted efflux transporter inhibitors - A solution to improve poor cellular accumulation of anti-cancer agents
Johanna Huttunen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1
Joseph Schoepfer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel Potent ABCB1 Modulator, Phenethylisoquinoline Alkaloid, Reverses Multidrug Resistance in Cancer Cell
Norihiko Sugisawa et al.
MOLECULAR PHARMACEUTICS (2018)
A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: A Dual-Acting Weapon for Targeting DNA in Cancer Cells
Diego Montagner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Taxifolin Resensitizes Multidrug Resistance Cancer Cells via Uncompetitive Inhibition of P-Glycoprotein Function
Hsiu-Ju Chen et al.
MOLECULES (2018)
Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway through TSC 1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo
Min Chen et al.
ONCOTARGETS AND THERAPY (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?
Adrian C. Jaramillo et al.
CANCER DRUG RESISTANCE (2018)
SH003 enhances paclitaxel chemosensitivity in MCF-7/PAX breast cancer cells through inhibition of MDR1 activity
Hyeong Sim Choi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Cytotoxicity and Efflux Pump Inhibition Induced by Molybdenum Disulfide and Boron Nitride Nanomaterials with Sheetlike Structure
Su Liu et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2017)
Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer
Prashant Joshi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-B signaling
Yandong Lu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
Robert Cornelison et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression
Zhenyou Zou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
Saikat Dewanjee et al.
MOLECULES (2017)
ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells
Seyed Abbas Mirzaei et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter
Branka Radic-Sarikas et al.
SCIENTIFIC REPORTS (2017)
Improving Access to Cancer Treatments: The Role of Biosimilars
Rakesh Chopra et al.
JOURNAL OF GLOBAL ONCOLOGY (2017)
Reversal of ABCB1 mediated efflux by imatinib and nilotinib in cells expressing various transporter levels
Petr Mlejnek et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line
Mario Gajdacs et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Identification of Important Compounds Isolated from Natural Sources that Have Activity Against Multidrug-resistant Cancer Cell Lines: Effects on Proliferation, Apoptotic Mechanism and the Efflux Pump Responsible for Multi-resistance Phenotype
Leonard Amaral et al.
ANTICANCER RESEARCH (2016)
The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug Thioridazine
Gabriella Spengler et al.
ANTICANCER RESEARCH (2016)
Nano-formulations of drugs: Recent developments, impact and challenges
Jaison Jeevanandam et al.
BIOCHIMIE (2016)
The 5-aromatic hydantoin-3-acetate derivatives as inhibitors of the tumour multidrug resistance efflux pump P-glycoprotein (ABCB1): Synthesis, crystallographic and biological studies
Ewa Zeslawska et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen et al.
CANCER LETTERS (2016)
Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
Wen Li et al.
DRUG RESISTANCE UPDATES (2016)
Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1
Sung-Han Hsiao et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function
Sen-Ling Feng et al.
PHARMACOLOGICAL RESEARCH (2016)
Cisplatin resistance and opportunities for precision medicine
Lauren Amable
PHARMACOLOGICAL RESEARCH (2016)
Jatrophane diterpenes and cancer multidrug resistance-ABCB1 efflux modulation and selective cell death induction
Mariana Alves Reis et al.
PHYTOMEDICINE (2016)
Inhibition of multixenobiotic resistance transporters (MXR) by silver nanoparticles and ions in vitro and in Daphnia magna
Anastasia Georgantzopoulou et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2016)
SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/P-glycoprotein via EGFR/ERK/AP-1 pathway
Haitao Guan et al.
TUMOR BIOLOGY (2016)
Role of Biologics in First-Line Treatment of Colorectal Cancer
Amit Mahipal et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Historical review of the causes of cancer
Clarke Brian Blackadar
WORLD JOURNAL OF CLINICAL ONCOLOGY (2016)
Mechanisms of doxorubicin resistance in hepatocellular carcinoma
Josiah Cox et al.
HEPATIC ONCOLOGY (2016)
Inhibition of MDR1 Overcomes Brentuximab Vedotin Resistance in Hodgkin Lymphoma Cell Line Model and Is Synergistic with Brentuximab Vedotin in Mouse Xenograft Model
Robert W. Chen et al.
BLOOD (2016)
Icariin Enhances Cytotoxicity of Doxorubicin in Human Multidrug-Resistant Osteosarcoma Cells by Inhibition of ABCB1 and Down-Regulation of the PI3K/Akt Pathway
Zhendong Wang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles
Bo Xiao et al.
BIOMATERIALS (2015)
Discovery of substituted 1,4-dihydroquinolines as novel class of ABCB1 modulators
Marc Hemmer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
Khalid O. Alfarouk et al.
CANCER CELL INTERNATIONAL (2015)
Pgp efflux pump decreases the cytostatic effect of CENP-E inhibitor GSK923295
Sergey O. Tcherniuk et al.
CANCER LETTERS (2015)
An overview of FDA-approved biologics medicines
Michael S. Kinch
DRUG DISCOVERY TODAY (2015)
A review on anticancer potential of bioactive heterocycle quinoline
Obaid Afzal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Demethoxycurcumin Modulates Human P-Glycoprotein Function via Uncompetitive Inhibition of ATPase Hydrolysis Activity
Yu-Ning Teng et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)
New trends for overcoming ABCG2/BCRP-mediated resistance to cancer therapies
David Westover et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity
Ramesh Mudududdla et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Renata Silva et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells
Biao Wang et al.
TUMOR BIOLOGY (2015)
Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells
Wenzhe Ma et al.
SCIENTIFIC REPORTS (2015)
Phenotypic screens as a renewed approach for drug discovery
Wei Zheng et al.
DRUG DISCOVERY TODAY (2013)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Alfred H. Schinkel et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Efflux Pump-Mediated Resistance in Chemotherapy
P. O. Ughachukwu et al.
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2012)
Sildenafil Reverses ABCB1-and ABCG2-Mediated Chemotherapeutic Drug Resistance
Zhi Shi et al.
CANCER RESEARCH (2011)
Pathology of Lung Cancer
William D. Travis
CLINICS IN CHEST MEDICINE (2011)
Structural and Functional Properties of Human Multidrug Resistance Protein 1 (MRP1/ABCC1)
S. -M. He et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism
S. Fais
JOURNAL OF INTERNAL MEDICINE (2010)
ABC transporters in cancer: more than just drug efflux pumps
Jamie I. Fletcher et al.
NATURE REVIEWS CANCER (2010)
The role of biologics in stomach cancer
Florian Lordick et al.
TARGETED ONCOLOGY (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein
Jun-Sheng Wang et al.
PSYCHOPHARMACOLOGY (2006)
Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)
RG Deeley et al.
FEBS LETTERS (2006)
Target-based drug discovery: is something wrong?
F Sams-Dodd
DRUG DISCOVERY TODAY (2005)
Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts
SS Cao et al.
CLINICAL CANCER RESEARCH (2004)
Structure and function of efflux pumps that confer resistance to drugs
MI Borges-Walmsley et al.
BIOCHEMICAL JOURNAL (2003)
Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers
GP Pfeifer et al.
ONCOGENE (2002)
Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution
S Conrad et al.
JOURNAL OF HUMAN GENETICS (2001)
Share Paper
